Pre-hospital ECPR: challenges and benefits
Survival from out-of-hospital cardiac arrest (OHCA) has remained low despite advances in resuscitation science. Hospital-based extracorporeal cardiopulmonary resuscitation (ECPR) is a novel use of an established technology that provides greater blood flow and oxygen delivery during cardiac arrest than closed chest compressions. Pre-hospital delivery of ECPR concurrent with conventional resuscitation is one approach to improving outcomes after OHCA, says an article in the Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.
During conventional resuscitation, external chest compressions generate both coronary perfusion pressure and cardiac output. Coronary perfusion pressure dictates myocardial reperfusion, which in turn is critical to achieve return of spontaneous circulation (ROSC). Cardiac output dictates organ and cerebral perfusion, which is critical to prevent irreversible ischaemic injury.
Optimal conventional cardiopulmonary resuscitation (CCPR) typically generates only a fraction of normal cardiac output (cardiac index ~ 0.6 L.min-1.m-2), commonly referred to as the "low-flow" state. A lengthy low-flow state during prolonged CCPR increases the risk of multi-organ failure and hypoxic brain injury after ROSC, the article notes.
ECPR is the implementation of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) during ongoing resuscitation attempts in cardiac arrest. In VA-ECMO, a venous drainage cannula is placed to drain blood which is then pumped through a membrane oxygenator before being returned under pressure into a central artery through a return cannula. There are various configurations of where cannulas can be placed, although the most common selection in cardiac arrest is a femoral vein drainage cannula and a femoral artery return cannula.
"Compared to CCPR, ECPR improves blood flow (cardiac index ~ 2.0 L.min-1.m-2) and oxygen delivery during cardiac arrest with the aim of preventing irreversible end-organ damage and hypoxic brain injury. It can also facilitate therapies such as coronary angiography or fibrinolysis to treat the primary cause of OHCA," the article says.
The ideal therapeutic window for ECPR is within 60 minutes after collapse. Patients most likely to benefit from ECPR (e.g., younger age, witnessed, bystander CPR, shockable rhythm) also have the greatest probability of ROSC with CCPR during the first 10–15 minutes after collapse.
Pre-hospital ECPR seeks to minimise low-flow time by delivering ECPR to the patient concurrently with initial CCPR, according to the article. While posing unique logistical challenges, this strategy may shorten the delay to commencement of ECPR. Forthcoming prospective trials of pre-hospital ECPR (NCT02527031) and hospital-based ECPR (NCT01511666, NCT02832752, NCT03065647) will aid in refining selection criteria and identifying which patients may benefit from pre-hospital ECPR compared to hospital-based ECPR or CCPR.
"The ideal dispatch and deployment strategy for pre-hospital ECPR teams has yet to be determined, and will likely depend on unique features of each pre-hospital system of care. The clinical benefits of rapid response and shorter low-flow time need to be balanced with the costs of over-triage and resource utilisation," the article notes. "Despite its challenges, pre-hospital ECPR offers the potential to dramatically improve clinical outcomes for a subset of OHCA patients."
Source: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Image Credit: Pixabay
Published on : Tue, 10 Apr 2018
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
Features The SynoVent E5 is the ventilator you need with the interface you want. It does not only include advanced ventilator functionality for patients ranging from infant to adult, but also a modern, easy-to-use interface. The display can be...
A high-end ventilator featured with 1080P HD wide screen, combines an intuitive customized UI with powerful assistive tools and modules. Operate with Ease In the modern busy clinical environment, ease of use is a fundamental requirement for all...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.